Find your next paid study

Sanofi Pasteur, a Sanofi CompanyNCT06316297

~$150 – $4,500

Actual pay is set by the research site.

Longitudinal Study of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Post-Acute Sequelae of COVID-19 (PASC)

This study will examine how common Long COVID is and how symptoms may persist over time in people who have previously had COVID-19. Researchers will collect in…

SARS CoV-2 Post-Acute Sequelae

University of North Carolina, Chapel HillNCT07781501

Actual pay is set by the research site.

Negative AffectivityNon-invasive Brain StimulationPlacebo Effect+1 more

Neural Mechanisms of Interpersonal Expectations on Negative Affect

The goal of this clinical trial is to learn whether non-invasive brain stimulation, called transcranial temporal interference stimulation (tTIS), can reduce ne…

Trustees of Dartmouth CollegeNCT06980090

Actual pay is set by the research site.

Effect of Acute Intermittent Hypoxia in Healthy Individuals

The use of acute intermittent hypoxia (AIH) has been examined in animal and human studies to gain an understanding of its effect on spinal excitability and syn…

Healthy

Shirley Ryan AbilityLabNCT04691518

~$10 – $1,125

Actual pay is set by the research site.

CoughVocal Cord AtrophyVocal Cord Paresis+3 more

Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures: A Pilot Study

Investigators will assess the usefulness of using ultrasound in office procedures for laryngology interventions. Participants who qualify will be adults who ar…

Weill Medical College of Cornell UniversityNCT06579989

Actual pay is set by the research site.

Social MediaDigital Well-being

Digital Habit and Neural Indicators of Well-Being

Social media apps are designed to make opening and continuing to use them easy, which may contribute to habitual or unwanted use. This study will test whether …

University of Southern CaliforniaNCT07829211

Actual pay is set by the research site.

Phase 1

Integrated Glofit and Ibrutinib as Novel Immune Therapy Evaluation in Treatment-Naive Mantle Cell Lymphoma (IGNITE MCL): A Phase Ib/II Study of Glofitamab Plus Ibrutinib With Obinutuzumab Pretreatment in MCL Patients ≥ 65 or Ages 18-64 With High-Risk Features

This phase IB/II trial tests the safety, side effects and effectiveness of glofitamab plus ibrutinib with obinutuzumab for the treatment of patients with mantl…

Mantle Cell Lymphoma

OHSU Knight Cancer InstituteNCT06357676

~$150 – $4,500

Actual pay is set by the research site.

Phase 1

Deformable Tissue Modelling and Augmented Reality Based Guidance for Head and Neck Tumor Re-Resection Task

Head and neck cancers have one of the highest recurrence rates among solid malignancies, and recurrence is strongly correlated with overall survival. Reducing …

PhysicianSurgeonResident Doctor+3 more

Vanderbilt University Medical CenterNCT07686211

~$150 – $3,000

Actual pay is set by the research site.

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

The purpose of this study is to identify multiple myeloma in the precancerous MGUS stage in order to reduce the risk of delayed diagnosis of multiple myeloma, …

Multiple MyelomaMultiple Myeloma ProgressionMonoclonal Gammopathy of Undetermined Significance (MGUS)+2 more

Wake Forest University Health SciencesNCT06644625

Actual pay is set by the research site.

Phase 3

A 52-week Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess Efficacy and Safety of Remibrutinib (LOU064) in Adult and Adolescent Participants With IgE-mediated Food Allergy

The purpose of this Phase III study is to evaluate the clinical efficacy and safety of remibrutinib in participants with peanut, or cow's milk ("milk", cooked …

IgE-Mediated Food AllergyPeanut AllergyCow Milk Allergy+1 more

Novartis PharmaceuticalsNCT07768371

~$50 – $2,100

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer may have a higher chance of getting wo…

Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms

Merck Sharp & Dohme LLCNCT06966700

~$50 – $2,100

Actual pay is set by the research site.

Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy

Estrogen-dominant gender-affirming hormone therapy (GAHT) is standard of care for transgender women and gender-diverse individuals and typically consists of es…

Muscle Mass and Strength